High sugar-sweetened beverage intake predicts adverse physical, emotional, and sleep health trajectories in adolescents: a 4-year prospective cohort study
Frontiers in Public Health · 14.01.2026 · 13
DOI: 10.3389/fpubh.2025.1754072 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 14.01.2026. Verfasst von Zeyu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Educational Science, Xinjiang Normal University, Urumqi, China. Hauptthemen laut MEDLINE: Sugar-Sweetened Beverages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Excessive consumption of sugar-sweetened beverages (SSBs) is a major source of added sugars among adolescents and has been associated with adverse cardiometabolic, emotional, and sleep-related outcomes. However, longitudinal evidence from Asian populations remains limited. This 4-year prospective cohort study examined the associations between SSB intake and multiple health trajectories during adolescence.
Methods
A total of 1,204 adolescents (baseline age: 12.41 ± 0.89 years; 51.2% girls) from 12 secondary schools in Chongqing, China, were followed annually from 2021 to 2024. SSB intake was assessed using a validated food frequency questionnaire adapted for use among Chinese adolescents. Outcomes included body mass index (BMI), body fat percentage, systolic blood pressure, depressive symptoms (CES-D), academic burnout, and sleep quality (Pittsburgh Sleep Quality Index, PSQI). Longitudinal associations were examined using linear mixed-effects models adjusted for age, sex, socioeconomic status, physical activity, screen time, and baseline BMI.
Results
Higher SSB intake was associated with significantly steeper increases in BMI (mean increase: +2.87 vs. +1.90 kg/m 2 ), body fat percentage (+4.6% vs. +2.1%), systolic blood pressure (+4.8 vs. +2.1 mmHg), depressive symptoms (CES-D: +6.0 vs. +2.0 points), and sleep disturbance (PSQI: +1.3 vs. +0.4 points) compared with the lowest intake tertile (all p < 0.01). Adolescents in the highest SSB tertile exhibited a 62% greater increase in depressive symptoms over 4 years. Participants who reduced SSB intake by ≥30% showed significantly smaller increases across physical, emotional, and sleep-related outcomes.
Conclusion
High SSB intake is prospectively associated with unfavorable cardiometabolic, emotional, and sleep-related health trajectories during adolescence. Reducing SSB consumption represents a promising and actionable strategy for school-based health promotion and chronic disease prevention among Asian youth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Educational Science, Xinjiang Normal University, Urumqi, China.
- Biological Education Teaching and Research Group, Chongqing Tongnan Experimental Middle School, Chongqing, China.
- English Education Teaching and Research Group, Suqian Chongwen Junior Middle School, Suqian, China.
- School of Accounting, Nanjing University of Finance and Economics, Nanjing, Jiangsu, China.
Zitieren
APA
Zhang, Z., Li, W., Zhang, M., & Zhang, Y. (2026). High sugar-sweetened beverage intake predicts adverse physical, emotional, and sleep health trajectories in adolescents: a 4-year prospective cohort study. Frontiers in Public Health, 13. https://doi.org/10.3389/fpubh.2025.1754072
Vancouver
Zhang Z, Li W, Zhang M, Zhang Y. High sugar-sweetened beverage intake predicts adverse physical, emotional, and sleep health trajectories in adolescents: a 4-year prospective cohort study. Frontiers in Public Health. 2026;13. doi:10.3389/fpubh.2025.1754072
BibTeX
@article{Zhang2026,
author = {Zhang, Zeyu and Li, Wanjun and Zhang, Min and Zhang, Yike},
title = {High sugar-sweetened beverage intake predicts adverse physical, emotional, and sleep health trajectories in adolescents: a 4-year prospective cohort study},
journal = {Frontiers in Public Health},
year = {2026},
volume = {13},
doi = {10.3389/fpubh.2025.1754072}
}
EUVIMED